PRKAA2 and depressive symptom measurement: Consistent with these data, mice treated with CC for 5 days had reduced levels of p-AMPK and increased expression of p47phox and gp91phox in the hippocampus and exhibited depression-like behaviors in the SIT, TST and FST.